SCHEMBL2785718

SCHEMBL2785718

CC1(Cc2cc(F)cc(F)c2)C(=O)Nc2c(-c3cccnc3)cc(-c3cccc(C(F)(F)F)c3)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 1/20 0.39
▸ GRIN1 Q05586 5/20 0.39
▸ GRIN2B Q13224 5/20 0.39
▸ NPY5R Q15761 1/20 0.38
▸ KCNA5 P22460 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ CLK1 P49759 1/20 0.37
▸ DYRK1A Q13627 1/20 0.37
▸ PDK2 Q15119 4/20 0.36
▸ CYP19A1 P11511 1/20 0.36
▸ CYP11B1 P15538 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ PIK3CD O00329 1/20 0.35
▸ HCRTR1 O43613 1/20 0.35
▸ HCRTR2 O43614 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2786628 0.92 GRIN1 (0.38) GRIN1GRIN2BCYP11B1CYP11B2
SCHEMBL2785099 0.91 EPHX2 (0.42) GRIN1GRIN2BPIK3CD
SCHEMBL2785994 0.90 GRIN1 (0.38) PIM1GRIN1GRIN2BKCNA5KCNH2
SCHEMBL2786610 0.88 HDAC1 (0.38) GRIN1GRIN2BPIK3CD
SCHEMBL2787299 0.78 GRIN1 (0.41) GRIN1GRIN2BPIK3CD
SCHEMBL3020986 0.78 PGR (0.55) PIK3CD
SCHEMBL2785545 0.77 PGR (0.46) GRIN1GRIN2BPIK3CD
SCHEMBL2785774 0.76 HDAC1 (0.37) PIK3CDHCRTR1
SCHEMBL1951405 0.76 PARP10 (0.43) PIM1GRIN1GRIN2BPIK3CD
SCHEMBL3037421 0.75 GRIN1 (0.40) PIM1GRIN1GRIN2BKCNA5KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2209373-A1 N-SUBSTITUTED OXINDOLINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS Merck Sharp & Dohme Corp. (US) 2010-07-28 — — EP claimed
WO-2009045386-A1 N-SUBSTITUTED OXINDOLINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS MERCK & CO., INC. (US) 2009-04-09 — — WO claimed
Send feedback